Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
The host immune response plays a critical role in the immunopathology of SARS-CoV2. Here the authors combine a systems biology approach to implicate monocytes as key drivers of cytokine storm and disturbed neutrophil activation in COVID-19 disease severity.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c55c079574c54862a899d42bf41ed851 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c55c079574c54862a899d42bf41ed851 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c55c079574c54862a899d42bf41ed8512021-12-02T15:23:18ZMonocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity10.1038/s41467-021-24360-w2041-1723https://doaj.org/article/c55c079574c54862a899d42bf41ed8512021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24360-whttps://doaj.org/toc/2041-1723The host immune response plays a critical role in the immunopathology of SARS-CoV2. Here the authors combine a systems biology approach to implicate monocytes as key drivers of cytokine storm and disturbed neutrophil activation in COVID-19 disease severity.L. VanderbekeP. Van MolY. Van HerckF. De SmetS. Humblet-BaronK. MartinodA. AntoranzI. ArijsB. BoeckxF. M. BosisioM. CasaerD. DauweW. De WeverC. DoomsE. DreesenA. EmmaneelJ. FiltjensM. GouwyJ. GunstG. HermansS. JansenK. LagrouA. ListonN. LorentP. MeerssemanT. MercierJ. NeytsJ. OdentD. PanovskaP. A. PenttilaE. PolletP. ProostJ. QianK. QuintelierJ. RaesS. RexY. SaeysJ. SprootenS. TejparD. TestelmansK. ThevissenT. Van BuytenJ. VandenhauteS. Van GassenL. C. Velásquez PereiraR. VosB. WeynandA. WilmerJ. YserbytA. D. GargP. MatthysC. WoutersD. LambrechtsE. WautersJ. WautersNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q L. Vanderbeke P. Van Mol Y. Van Herck F. De Smet S. Humblet-Baron K. Martinod A. Antoranz I. Arijs B. Boeckx F. M. Bosisio M. Casaer D. Dauwe W. De Wever C. Dooms E. Dreesen A. Emmaneel J. Filtjens M. Gouwy J. Gunst G. Hermans S. Jansen K. Lagrou A. Liston N. Lorent P. Meersseman T. Mercier J. Neyts J. Odent D. Panovska P. A. Penttila E. Pollet P. Proost J. Qian K. Quintelier J. Raes S. Rex Y. Saeys J. Sprooten S. Tejpar D. Testelmans K. Thevissen T. Van Buyten J. Vandenhaute S. Van Gassen L. C. Velásquez Pereira R. Vos B. Weynand A. Wilmer J. Yserbyt A. D. Garg P. Matthys C. Wouters D. Lambrechts E. Wauters J. Wauters Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
description |
The host immune response plays a critical role in the immunopathology of SARS-CoV2. Here the authors combine a systems biology approach to implicate monocytes as key drivers of cytokine storm and disturbed neutrophil activation in COVID-19 disease severity. |
format |
article |
author |
L. Vanderbeke P. Van Mol Y. Van Herck F. De Smet S. Humblet-Baron K. Martinod A. Antoranz I. Arijs B. Boeckx F. M. Bosisio M. Casaer D. Dauwe W. De Wever C. Dooms E. Dreesen A. Emmaneel J. Filtjens M. Gouwy J. Gunst G. Hermans S. Jansen K. Lagrou A. Liston N. Lorent P. Meersseman T. Mercier J. Neyts J. Odent D. Panovska P. A. Penttila E. Pollet P. Proost J. Qian K. Quintelier J. Raes S. Rex Y. Saeys J. Sprooten S. Tejpar D. Testelmans K. Thevissen T. Van Buyten J. Vandenhaute S. Van Gassen L. C. Velásquez Pereira R. Vos B. Weynand A. Wilmer J. Yserbyt A. D. Garg P. Matthys C. Wouters D. Lambrechts E. Wauters J. Wauters |
author_facet |
L. Vanderbeke P. Van Mol Y. Van Herck F. De Smet S. Humblet-Baron K. Martinod A. Antoranz I. Arijs B. Boeckx F. M. Bosisio M. Casaer D. Dauwe W. De Wever C. Dooms E. Dreesen A. Emmaneel J. Filtjens M. Gouwy J. Gunst G. Hermans S. Jansen K. Lagrou A. Liston N. Lorent P. Meersseman T. Mercier J. Neyts J. Odent D. Panovska P. A. Penttila E. Pollet P. Proost J. Qian K. Quintelier J. Raes S. Rex Y. Saeys J. Sprooten S. Tejpar D. Testelmans K. Thevissen T. Van Buyten J. Vandenhaute S. Van Gassen L. C. Velásquez Pereira R. Vos B. Weynand A. Wilmer J. Yserbyt A. D. Garg P. Matthys C. Wouters D. Lambrechts E. Wauters J. Wauters |
author_sort |
L. Vanderbeke |
title |
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
title_short |
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
title_full |
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
title_fullStr |
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
title_full_unstemmed |
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity |
title_sort |
monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of covid-19 disease severity |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/c55c079574c54862a899d42bf41ed851 |
work_keys_str_mv |
AT lvanderbeke monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT pvanmol monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT yvanherck monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT fdesmet monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT shumbletbaron monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT kmartinod monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT aantoranz monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT iarijs monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT bboeckx monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT fmbosisio monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT mcasaer monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT ddauwe monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT wdewever monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT cdooms monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT edreesen monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT aemmaneel monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jfiltjens monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT mgouwy monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jgunst monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT ghermans monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT sjansen monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT klagrou monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT aliston monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT nlorent monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT pmeersseman monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT tmercier monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jneyts monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jodent monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT dpanovska monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT papenttila monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT epollet monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT pproost monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jqian monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT kquintelier monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jraes monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT srex monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT ysaeys monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jsprooten monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT stejpar monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT dtestelmans monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT kthevissen monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT tvanbuyten monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jvandenhaute monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT svangassen monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT lcvelasquezpereira monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT rvos monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT bweynand monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT awilmer monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jyserbyt monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT adgarg monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT pmatthys monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT cwouters monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT dlambrechts monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT ewauters monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity AT jwauters monocytedrivenatypicalcytokinestormandaberrantneutrophilactivationaskeymediatorsofcovid19diseaseseverity |
_version_ |
1718387291718680576 |